Veterinary Therapeutics
(Preclinical-Bioanalytical)

To accelerate the transition of novel drugs into clinical trials, Cliantha Research (Scarborough, Canada) offers a high-quality bioanalytical veterinary program designed to address regulatory requirements and streamline IND submissions. Our regulated Preclinical-Bioanalytical Services support toxicology activities for small-molecule drugs in full alignment with global Good Laboratory Practice (GLP) standards.

Since 2014, our bioanalytical laboratory has delivered customized assay development and validation for both Branded and Generic Veterinary Pharmaceuticals. With seasoned scientific leadership and proven expertise, we ensure successful outcomes across every project.

GLP and Non-GLP Non-Clinical Animal Studies

  • Fit-To-Purpose Method Development: 10 days and Fit-To-Purpose Pilot Study Sample Analysis: 5 days
  • Client Query Management: Within 24 hours
  • Biological Species: dogs, cats, horses, rats, etc.,

GLP (Animal) Bioanalytical Studies

  • >45 validations in compliance with FDA and OECD GLPs
  • MV Reports approved by FDA CVM
Biological Species Matrix Analyte
Cat
Blood
Cyclosporine Rapamycin
Plasma
Amoxicillin Amoxicillin/Clavulanate Acid Clavulanic Acid Enrofloxacin Furosemide Marbofloxacin Milbemycin Oxime Mirtazapine Praziqantel Pyrantel Ritonavir
Dog
Blood
Rapamycin Cyclosporin
Plasma
Enrofloxacin Firocoxib Fluralaner Furosemide Ivermectin Keto-trilostane Levothyroxine Lufenuron Marbofloxacin Maropitant Meloxicam Methimazole Methylprednisolone Milbemycin Oxime Moxidectin Nordiazepam Oclacitib Prednisolone Phenylpropanolamine Pimobendan Praziquantel Tremaprazine Trilostane Trilostane
Serum
Grapiprant
Horse
Plasma
Firocoxib Ivermectin Omeprazole Moxidectin Pergolide Praziquantel
Rat
Plasma
Nitroso Bumetanide